Evidence map›Paper›PMID 42866691›Full record

ArticleResearch connections2026

Community-based interventions to improve hepatitis C linkage to care among people with substance use disorders in Southwest Virginia: a pragmatic sequential cohort study.

Mariana Gomez de la Espriella, Merly Konathapally, Sarah Henrickson Parker, Cynthia Morrow, Marrieth Rubio, Tara P Menon, Cara Ravagli, Anthony Baffoe-Bonnie

Abstract read
In one paragraph

Article in Research connections, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mariana Gomez de la EspriellaVirginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA 24016, United States.ORCID https://orcid.org/0000-0001-8963-9959
Merly KonathapallyDepartment of Internal Medicine, Mary Washington Healthcare, Fredericksburg, VA 22401, United States.
Sarah Henrickson ParkerVirginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA 24016, United States.
Cynthia MorrowVirginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA 24016, United States.
Marrieth RubioDepartment of Internal Medicine, Carilion Clinic, Roanoke, VA 24014, United States.
Tara P MenonVirginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA 24016, United States.
Cara RavagliDepartment of Internal Medicine, Carilion Clinic, Roanoke, VA 24014, United States.
Anthony Baffoe-BonnieVirginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA 24016, United States.ORCID https://orcid.org/0000-0002-6316-7719

Funding

The integrated Translational Health Research Institute of Virginia (iTHRIV): Using Data to Improve HealthUL1TR003015 · NCATS · UNIVERSITY OF VIRGINIA · PI BROWN, DONALD E, JOHNSTON, KAREN C. · 2019 to 2023
$20.3M
NCATS NIH HHS UL1 TR003015
6 · The paper itself

Abstract

In 2024, the reported hepatitis C virus (HCV) case rate in Roanoke City was nearly three times the rate of the state of Virginia, reflecting the disproportionate impact of the opioid epidemic in the region. Despite highly effective direct-acting antiviral therapies, substantial barriers to linkage to care (LTC) persist among individuals with substance use disorders (SUDs). While prior studies suggest that patient navigation and financial support may improve LTC, evidence from rural and underserved settings remains limited. This study aims to evaluate community-based interventions designed to improve HCV LTC among individuals with SUD in Southwest Virginia. We conducted a pragmatic, non-randomized, sequential cohort pilot study to evaluate the impact of iteratively refined community-based interventions on LTC. A total of 60 adults with detectable HCV RNA and SUD were enrolled sequentially into four cohorts (control and three intervention groups). All participants received peer support; intervention components were modified across cohorts to address observed barriers to care. The primary outcome was attendance at an outpatient HCV visit within 180 days of enrolment. LTC was 3/15 (20%) in both the control group and Intervention 1, increasing to 6/15 (40%) in Intervention 2 and 11/15 (73%) in Intervention 3. Exploratory analyses demonstrated significantly higher attendance in Intervention 3 than in the control group (73% vs. 20%,

Indexed as

community-based interventionshepatitis Clinkage to caresubstance use disorderstelehealth

Identifiers

PMID42866691
PMCPMC13657273

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.